The Use of Probiotics in Preterm Infants
6
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Probiotics are live microorganisms that positively affect host health by altering the composition of the host microbiota. Gastrointestinal dysbiosis refers to adverse alterations of the intestinal flora and is associated with several diseases, including necrotizing enterocolitis, late-onset sepsis in preterm infants as well as atopic disease, colic, diabetes, and diarrhea in term infants. The risk factors for gastrointestinal dysbiosis are preterm birth, cesarean section delivery, and formula feeding, in contrast to term birth infants, vaginal delivery and breast milk feeding. Probiotics have been used to restore synbiosis in infants with gastrointestinal dysbiosis. Probiotics inhibit colonization of pathogenic bacteria in the gastrointestinal tract, thereby improving the barrier function of the gastrointestinal tract, and the immune function. In preterm infants, probiotics reduce mortality as well as rates of necrotizing enterocolitis and late-onset sepsis. The combined use of probiotics such as Lactobacillus and Bifidobacterium and the combination of probiotics with prebiotics yield better outcomes in the prevention of necrotizing enterocolitis than those achieved with a single pro- or prebiotic strain. However, the routine use of probiotics has been hindered by the lack of pharmaceutical-quality products, and a definite effect has yet to be demonstrated in preterm infants with a birth weight <1,000 g. Therefore, to reduce the risk of necrotizing enterocolitis in preterm infants, probiotics should be provided along with breast milk and other strategies aimed at preventing gastrointestinal dysbiosis.
Abstract
Probiotics are live microorganisms that positively affect host health by altering the composition of the host microbiota. Gastrointestinal dysbiosis refers to adverse alterations of the intestinal flora and is associated with several diseases, including necrotizing enterocolitis, late-onset sepsis in preterm infants as well as atopic disease, colic, diabetes, and diarrhea in term infants. The risk factors for gastrointestinal dysbiosis are preterm birth, cesarean section delivery, and formula feeding, in contrast to term birth infants, vaginal delivery and breast milk feeding. Probiotics have been used to restore synbiosis in infants with gastrointestinal dysbiosis. Probiotics inhibit colonization of pathogenic bacteria in the gastrointestinal tract, thereby improving the barrier function of the gastrointestinal tract, and the immune function. In preterm infants, probiotics reduce mortality as well as rates of necrotizing enterocolitis and late-onset sepsis. The combined use of probiotics such as Lactobacillus and Bifidobacterium and the combination of probiotics with prebiotics yield better outcomes in the prevention of necrotizing enterocolitis than those achieved with a single pro- or prebiotic strain. However, the routine use of probiotics has been hindered by the lack of pharmaceutical-quality products, and a definite effect has yet to be demonstrated in preterm infants with a birth weight <1,000 g. Therefore, to reduce the risk of necrotizing enterocolitis in preterm infants, probiotics should be provided along with breast milk and other strategies aimed at preventing gastrointestinal dysbiosis.
참고문헌 (44)
- Zbinden A, "Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy", Neonatology, 107, pp.56~59 (2015)
- Di Mauro A, "Gastrointestinal function development and microbiota", Ital J Pediatr, 39, pp.15~ (2013)
- Underwood MA, "The microbiota of the extremely preterm infant", Clin Perinatol, 44, pp.407~427 (2017)
- Underwood MA, "Neonatal intestinal dysbiosis", J Perinatol, 40, pp.1597~1608 (2020)
- Poindexter B, "Use of probiotics in preterm infants", Pediatrics, 147, pp.e2021051485~ (2021)
- Patel RM, "Probiotics for preterm infants: which one(s) to choose?", Pediatrics, 147, pp.e2020039735~ (2021)
- Johnson-Henry KC, "Probiotics, prebiotics, and synbiotics for the prevention of necrotizing enterocolitis", Adv Nutr, 7, pp.928~937 (2016)
- Underwood MA, "A randomized placebo-controlled comparison of 2 prebiotic", probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids, 2009, pp.48, 216~225
- Buccigrossi V, "Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation", Pediatr Res, 61, pp.410~414 (2007)
- Senn V, "Microbial colonization from the fetus to early childhood : a comprehensive review", Front Cell Infect Microbiol, 10, pp.573735~ (2020)
- D’Argenio V, "The prenatal microbiome : a new player for human health", High Throughput, 7, pp.38~ (2018)
- Milani C, "The first microbial colonizers of the human gut : composition, activities, and health implications of the infant gut microbiota", Microbiol Mol Biol Rev, 81, pp.e00036-17~ (2017)
- Gritz EC, "The human neonatal gut microbiome : a brief review", Front Pediatr, 3, pp.17~ (2015)
- Westerbeek EA, "The intestinal bacterial colonisation in preterm infants : a review of the literature", Clin Nutr, 25, pp.361~368 (2006)
- Patel RM, "Probiotics and necrotizing enterocolitis", Semin Pediatr Surg, 27, pp.39~46 (2018)
- Patel RM, "Probiotic bacteria induce maturation of intestinal claudin 3expression and barrier function", Am J Pathol, 180, pp.626~635 (2012)
- Sharif S, "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants", Cochrane Database Syst Rev, 10, pp.CD005496~ (2020)
- Walker WA, "Mechanisms of action of probiotics", Clin Infect Dis, 46(Suppl 2), pp.S87~S91 (2008)
- Guo S, "Secretions of Bifidobacterium infantis and Lactobacillus acidophilus protect intestinal epithelial barrier function", J Pediatr Gastroenterol Nutr, 64, pp.404~412 (2017)
- Vincenzi A, "An evaluation of the effects of probiotics on tumoral necrosis factor(TNF-α)signaling and gene expression", Cytokine Growth Factor Rev, 57, pp.27~38 (2021)
- Lin PW, "Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation", Free Radic Biol Med, 47, pp.1205~1211 (2009)
- Litvak Y, "Dysbiotic Proteobacteria expansion : a microbial signature of epithelial dysfunction", Curr Opin Microbiol, 39, pp.1~6 (2017)
- Neu J, "Necrotizing enterocolitis", N Engl J Med, 364, pp.255~264 (2011)
- Hackam DJ, "Toll-like receptor-mediated intestinal inflammatory imbalance in the pathogenesis of necrotizing enterocolitis", Cell Mol Gastroenterol Hepatol, 6, pp.229~238 (2018)
- van den Akker CH, "Probiotics and preterm infants : a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics", J Pediatr Gastroenterol Nutr, 70, pp.664~680 (2020)
- Olsen R, "Prophylactic probiotics for preterm infants : a systematic review and meta-analysis of observational studies", Neonatology, 109, pp.105~112 (2016)
- Jacobs SE, "Probiotic effects on late-onset sepsis in very preterm infants : a randomized controlled trial", Pediatrics, 132, pp.1055~1062 (2013)
- Costeloe K, "Bifidobacterium breve BBG-001 in very preterm infants : a randomised controlled phase 3 trial", Lancet, 387, pp.649~660 (2016)
- Razak A, "Use of probiotics to prevent necrotizing enterocolitis : evidence to clinical practice", JAMA Pediatr, 175, pp.773~774 (2021)
- Chi C, "Effects of probiotics in preterm infants : a network meta-analysis", Pediatrics, 147, pp.e20200706~ (2021)
- Morgan RL, "Probiotics reduce mortality and morbidity in preterm, lowbirth-weight infants: a systematic review and network metaanalysis of randomized trials", Gastroenterology, 159, pp.467~480 (2020)
- Thomas DW, "Probiotics and prebiotics in pediatrics", Pediatrics, 126, pp.1217~1231 (2010)
- Marchand V, "Using probiotics in the paediatric population", Paediatr Child Health, 17, pp.575~576 (2012)
- Su GL, "AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders", Gastroenterology, 159, pp.697~705 (2020)
- Qiao LX, "Effect of early administration of probiotics on gut microflora and feeding in pre-term infants : a randomized controlled trial", J Matern Fetal Neonatal Med, 30, pp.13~16 (2017)
- Bertelli C, "Bifidobacterium longum bacteremia in preterm infants receiving probiotics", Clin Infect Dis, 60, pp.924~927 (2015)
- Esaiassen E, "Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics", Emerg Infect Dis, 22, pp.1664~1666 (2016)
- Jenke A, "Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy", Arch Dis Child Fetal Neonatal Ed, 97, pp.F217~F218 (2012)
- Vallabhaneni S, "Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement: Connecticut, 2014", MMWR Morb Mortal Wkly Rep, 64, pp.155~156 (2015)
- Salminen MK, "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland", Clin Infect Dis, 35, pp.1155~1160 (2002)
- Kane AF, "Routine supplementation of Lactobacillus rhamnosus GG and risk of necrotizing enterocolitis in very low birth weight infants", J Pediatr, 195, pp.73~79 (2018)
- 김선녀, "단장증후군 초미숙아에서 Probiotics 투약 후 동일 균주에 의한 패혈증 1례", Neonatal medicine, 22(3), pp.173~176 (2015), 대한신생아학회
- Jacobs SE, "Probiotics, prematurity and neurodevelopment : follow-up of a randomised trial", BMJ Paediatr Open, 1, pp.e000176~ (2017)
- Upadhyay RP, "Effect of prebiotic and probiotic supplementation on neurodevelopment in preterm very low birth weight infants : findings from a meta-analysis", Pediatr Res, 87, pp.811~822 (2020)